| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |